TrueWealth LLC’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
$7K Hold
66
﹤0.01% 515
2020
Q1
$6K Hold
66
﹤0.01% 515
2019
Q4
$7K Hold
66
﹤0.01% 511
2019
Q3
$6K Buy
66
+1
+2% +$87 ﹤0.01% 528
2019
Q2
$5K Sell
65
-101
-61% -$7.92K ﹤0.01% 562
2019
Q1
$13K Buy
166
+101
+155% +$7.96K 0.01% 416
2018
Q4
$5K Hold
65
﹤0.01% 538
2018
Q3
$5K Hold
65
﹤0.01% 606
2018
Q2
$5K Hold
65
﹤0.01% 602
2018
Q1
$5K Hold
65
﹤0.01% 568
2017
Q4
$5K Buy
+65
New +$4.38K ﹤0.01% 648

Other funds holding AZN

TrueWealth LLC's AZN Position: Q2 2020 in Review

TrueWealth LLC held its AstraZeneca (AZN) position steady in Q2 2020 at 66 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #515.

TrueWealth LLC first reported a position in AZN in Q4 2017 and has held it in 11 quarters since. The position peaked at $13K in Q1 2019. 669 funds tracked by Wall St. Rank hold AZN as of Q2 2020.

  • TrueWealth LLC held 66 shares of AstraZeneca worth $7K as of Q2 2020.
  • TrueWealth LLC left its AstraZeneca share count unchanged in Q2 2020.
  • AstraZeneca made up ﹤0.01% of TrueWealth LLC's portfolio in Q2 2020, its #515 holding.
  • TrueWealth LLC first reported a position in AstraZeneca in Q4 2017 and has held it in 11 quarters since.
  • TrueWealth LLC's AstraZeneca position peaked at $13K in Q1 2019.
  • 669 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2020.

Based on TrueWealth LLC's 13F filing for Q2 2020, filed 15 Jul 2020.